Stocktoria
Synergy CHC Corp. SNYR
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2013-11-08
Synergy CHC Corp. financials (annual)
Bars are annual figures from 2014 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.4M | $34.8M | $42.8M | $29.4M | $33.8M | $35.6M | $34.8M | $13.5M | $9,158 | — |
| Gross profit | $20.3M | $23.6M | $32.1M | $20.2M | $22.8M | $25.8M | $24.6M | $8.1M | $3,542 | — |
| Operating income | -$8.5M | $5.8M | $10.8M | -$8.0M | -$4.9M | $1.8M | $2.9M | $486,023 | -$958,094 | — |
| Interest expense | — | $1.5M | $1.7M | — | $1.1M | $1.0M | -$1.6M | -$958,740 | $1,998 | $3,705 |
| Income tax | $117,471 | $102,085 | $234,980 | -$131,537 | $247,694 | $316,012 | $944,358 | $389,945 | $0 | — |
| Net income | -$12.3M | $2.1M | $6.3M | -$9.2M | -$6.2M | $499,568 | -$796,161 | -$7.5M | -$960,092 | -$77,336 |
| EPS (diluted) | $-1.27 | $0.28 | $0.86 | $-0.10 | $-0.07 | $0.01 | — | — | — | — |
| Operating cash flow | -$2.6M | -$4.8M | $421,729 | $2.9M | $1.3M | -$831,070 | $6.0M | -$644,316 | -$489,175 | -$46,131 |
| Free cash flow | — | — | — | — | $1.2M | -$984,091 | $5.7M | -$652,149 | — | — |
| Cash & equivalents | $2.6M | $687,920 | $632,534 | $1.2M | $459,736 | $2.0M | $2.5M | $3.6M | $338 | $2,660 |
| Inventory | $3.7M | $1.7M | $3.7M | $1.9M | $2.7M | $2.8M | $1.1M | $686,655 | $26,064 | — |
| Total assets | $10.2M | $16.3M | $12.2M | $5.2M | $20.0M | $24.0M | $20.5M | $26.8M | $55,376 | $2,660 |
| Total liabilities | $33.3M | $33.0M | $39.5M | $10.4M | $16.0M | $14.6M | $13.4M | $21.3M | $181,042 | $17,791 |
| Shareholders' equity | -$23.1M | -$16.6M | -$27.3M | -$5.2M | $4.0M | $9.4M | $7.1M | $5.4M | -$125,666 | -$15,131 |
Growth · year-over-year · Revenue CAGR 175.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -12.8% | -18.6% | +45.7% | -13.2% | -5.0% | +2.2% | +158.9% | +146835.8% | — | — |
| Net income growth | -680.8% | -66.5% | — | — | -1333.2% | — | — | — | — | — |
| EPS growth | -553.6% | -67.4% | — | — | -800.0% | — | — | — | — | — |
| Free cash flow growth | — | — | — | — | — | -117.2% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.